Evidence map›Paper›PMID 40444116›Full record

ArticleFood science & nutrition2025

Identification of Soy-Derived Peptides With Micelle Disruption Activity of Secondary Bile Acids.

Shota Shimizu, Keita Hirano, Tsutomu Saito, Hirokazu Akiyama, Kazunori Shimizu, Hiroyuki Honda

Abstract read
In one paragraph

Article in Food science & nutrition, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Shota ShimizuDepartment of Biomolecular Engineering, Graduate School of Engineering Nagoya University Nagoya Japan.
Keita HiranoResearch Institute for Creating the Future Fuji Oil Holdings Inc. Ibaraki Japan.
Tsutomu SaitoResearch Institute for Creating the Future Fuji Oil Holdings Inc. Ibaraki Japan.
Hirokazu AkiyamaDepartment of Biomolecular Engineering, Graduate School of Engineering Nagoya University Nagoya Japan.
Kazunori ShimizuDepartment of Biomolecular Engineering, Graduate School of Engineering Nagoya University Nagoya Japan.
Hiroyuki HondaDepartment of Biomolecular Engineering, Graduate School of Engineering Nagoya University Nagoya Japan.ORCID https://orcid.org/0000-0002-7411-812X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Bile acids, which originate in the liver as primary bile acids, facilitate the absorption of lipophilic components into the intestines and exist as micellar structures. Intestinal bacteria convert primary bile acids to secondary bile acids, such as deoxycholic acid (DCA), which is associated with colorectal cancer. Therefore, their elimination from the body is preferred. Soy protein hydrolysates are known for their bile acid-binding properties, which prompted our investigation of DCA-specific binding and micelle-disrupting peptides. We designed a peptide library from eight soy protein sequences and selected 42 candidate peptides based on their DCA-binding activity. These peptides were synthesized, and their ability to disrupt bile acid micelles was assessed using a 96-well high-throughput assay system. Of the 42 peptides evaluated, 41 exhibited significant DCA micelle degradation, and 21 showed specific activity only for DCA micelles. Further research involved preparing soy protein pepsin hydrolysates and identifying 1,354 free peptides. Among these, 10 peptides containing sequences from the initial peptide library were identified. All peptides exhibited DCA micelle-disrupting activity. These peptides are believed to facilitate the excretion of secondary bile acids. Notably, FGSLRKNAM and SLRKNAM selectively disrupted DCA micelles without affecting the micelles of other bile acids. As these two peptides were also identified in the undigested high molecular weight fraction, they are considered key peptides with high potential for efficiently promoting the excretion of DCA.

Identifiers

PMID40444116
PMCPMC12121512

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.